Santen Pharmaceutical. (SZD.F) Q2 2024 Earnings

9MayConfirmed
Dec 17
Q4 2023
Q2 2024
0.1
9.97
19.84
29.71

Details

Expected EPS
0.1073510178035824
Actual EPS
0.1003606947222568
Surprise EPS
-0.01
Surprise Percent
+6.51%

Description

Santen Pharmaceutical. (SZD.F) has reported earnings of 0.1003606947222568 per share for Q2 2024.

0 Comments

Share your thoughts